SPHERTOX was financed in 2021 by the Norwegian Research Council under their scheme for Researcher Projects for Young Talents. 55 of the 540 applications (10%) were granted funding. The full title of the project is:
Hepatic 3D spheroids: the next generation of testing in toxicology (SPHERTOX)
The primary objective of SPHERTOX is to assess the performance of hepatic 3D spheroids from rainbow trout as an alternative chronic toxicity- and bioconcentration system, alone or in co-culture with other cell types, as an alternative and advanced in vitro model with increased comparability towards in vivo test systems.
The long-term goal of SPHERTOX is to develop a method applicable for regulatory purposes and international validation, which will significantly improve the hazard assessment of chemicals in regulatory programmes such as REACH.
To fulfil this objective, SPHERTOX will generate in silico and experimental data to develop and evaluate novel and alternative ecotoxicological test methods for fish, with the following main aims:
- Characterisation of the spheroid model's morphological and physiological properties during chemical exposure
- Establishment of 3D spheroids as a chronic low-dose and repeated exposure in vitro model
- Application of spheroids to measure low biotransformation rates of chemicals in bioconcentration assessment
- Generation of a multi-compartment co-culturing system using hepatic spheroids and primary gill cells for acute and chronic toxicity testing, mimicking an in vivo-like chemical flux scenario
- Improvement of in vitro to in vivo extrapolations by using 3D spheroids alone and/or in co-culture
- Development and implementation of a causal inference model to identify mechanistic interactions and confounding factors within in vitro and in vivo toxicity testing.
Development is underway for more physiologically relevant in vitro test systems that are more complex than single-cell models, and more alike the organ of interest (e.g. the liver). One such bioassay is the 3D organelle model, which consist of primary hepatic cells, or continuous cell lines, allowed to aggregate into 3D spheroids over a period of a few days. A viable 3D spheroid is 100-400 μm in diameter, consists of approx. 500-5000 cells per spheroid, and forms during 5-10 days of incubation.
Characterisation and evaluation of the 3D spheroids is necessary to unravel the assay's applicability as a novel in vitro model. Although 3D spheroids using hepatic primary cells have been developed, there is limited information on their characterisation and use in bioconcentration assessments, in particular for industrially relevant and slowly biotransformed hydrophobic chemicals, and there is no information on their use for chronic toxicity testing.
Co-cultures are highly relevant for toxicity testing and this will be investigated in combination with liver spheroids. Development and application of such systems will play a central role in research within synthetic biology and ecotoxicology, since they better reflect the gill-plasma-liver model in fish.
This project aims to develop a scientifically novel test paradigm that can replace, refine and reduce the use of fish in regulatory chemical hazard assessment.
SPHERTOX is a collaboration between NIVA, the University of Oslo, the University of Suffolk, University of Plymouth, Kings College London, and Givaudan.
Norecopa's Secretary is a member of the Scientific Advisory Committee (SAC) for the project. The SAC will facilitate expansion of the project's network within academia, industry and regulatory authorities, for dissemination, communication and exploitation of the data generated from the project. Members of the SAC include Dr. Adam Lillicrap, who was awarded Norecopa's 3R Prize in 2017 for his work in developing alternatives to animal tests in connection with monitoring of environmental hazards.
The project runs from the Autumn of 2021 until the summer of 2025.
Image by Maria T. Hultman
Did you find what you were looking for?Yes, I found it! No, I did not!
Thanks for your feedback! Please note that we cannot respond unless you supply your email address.
What are you looking for?
Please give us your feedback so we can improve the information on the page. Thank you in advance for your help. Please add your email address if you would like a reply.Please contact us by email if you have any questions.